Liminatus Pharma Warrants
LIMNW
24 hedge funds and large institutions have $95K invested in Liminatus Pharma Warrants in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.
2.3% less ownership
Funds ownership: 34.12% → 31.82% (-2.3%)
8% less funds holding
Funds holding: 26 → 24 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
76% less capital invested
Capital invested by funds: $400K → $95K (-$305K)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.41K |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.25K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$396 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$11.7K |
| 2 |
AWG
Alpha Wave Global
New York
|
-$10.7K |
| 3 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$2.22K |
| 4 |
GS
GTS Securities
New York
|
-$30 |
| 5 |
CS
Clear Street
New York
|
-$20 |
LIMNW Hedge Fund Activity: Q4 2025 in Review
24 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Liminatus Pharma Warrants (LIMNW) for Q4 2025, worth a combined $95K — down 76% from $400K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of LIMNW and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 1 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.41K. The largest seller was Nomura Holdings, exiting entirely with an estimated $11.7K sold.
- 24 institutional investors held Liminatus Pharma Warrants (LIMNW) as of Q4 2025, down from 26 in Q3 2025.
- Funds reported $95K of Liminatus Pharma Warrants stock for Q4 2025, down 76% quarter-over-quarter.
- 2 funds opened new Liminatus Pharma Warrants positions in Q4 2025 and 3 closed out, a net change of -1 holder.
- The largest Liminatus Pharma Warrants buyer in Q4 2025 was Susquehanna International Group, an estimated $2.41K added.
- The largest Liminatus Pharma Warrants seller in Q4 2025 was Nomura Holdings, an estimated $11.7K sold.
Based on aggregated 13F filings for Q4 2025.